Facets of individual-specific health signatures determined from longitudinal plasma proteome profiling

Background: Precision medicine approaches aim to tackle diseases on an individual level through molecular profiling. Despite the growing knowledge about diseases and the reported diversity of molecular phenotypes, the descriptions of human health on an individual level have been far less elaborate....

Full description

Bibliographic Details
Main Authors: Tea Dodig-Crnković, Mun-Gwan Hong, Cecilia Engel Thomas, Ragna S. Häussler, Annika Bendes, Matilda Dale, Fredrik Edfors, Björn Forsström, Patrik K.E. Magnusson, Ina Schuppe-Koistinen, Jacob Odeberg, Linn Fagerberg, Anders Gummesson, Göran Bergström, Mathias Uhlén, Jochen M. Schwenk
Format: Article
Language:English
Published: Elsevier 2020-07-01
Series:EBioMedicine
Subjects:
Online Access:http://www.sciencedirect.com/science/article/pii/S2352396420302292
id doaj-3bf396ecd736410fbedbd4648e4a6bf7
record_format Article
collection DOAJ
language English
format Article
sources DOAJ
author Tea Dodig-Crnković
Mun-Gwan Hong
Cecilia Engel Thomas
Ragna S. Häussler
Annika Bendes
Matilda Dale
Fredrik Edfors
Björn Forsström
Patrik K.E. Magnusson
Ina Schuppe-Koistinen
Jacob Odeberg
Linn Fagerberg
Anders Gummesson
Göran Bergström
Mathias Uhlén
Jochen M. Schwenk
spellingShingle Tea Dodig-Crnković
Mun-Gwan Hong
Cecilia Engel Thomas
Ragna S. Häussler
Annika Bendes
Matilda Dale
Fredrik Edfors
Björn Forsström
Patrik K.E. Magnusson
Ina Schuppe-Koistinen
Jacob Odeberg
Linn Fagerberg
Anders Gummesson
Göran Bergström
Mathias Uhlén
Jochen M. Schwenk
Facets of individual-specific health signatures determined from longitudinal plasma proteome profiling
EBioMedicine
Affinity proteomics
Longitudinal profiling
Plasma proteomics
pQTLs
Precision medicine
author_facet Tea Dodig-Crnković
Mun-Gwan Hong
Cecilia Engel Thomas
Ragna S. Häussler
Annika Bendes
Matilda Dale
Fredrik Edfors
Björn Forsström
Patrik K.E. Magnusson
Ina Schuppe-Koistinen
Jacob Odeberg
Linn Fagerberg
Anders Gummesson
Göran Bergström
Mathias Uhlén
Jochen M. Schwenk
author_sort Tea Dodig-Crnković
title Facets of individual-specific health signatures determined from longitudinal plasma proteome profiling
title_short Facets of individual-specific health signatures determined from longitudinal plasma proteome profiling
title_full Facets of individual-specific health signatures determined from longitudinal plasma proteome profiling
title_fullStr Facets of individual-specific health signatures determined from longitudinal plasma proteome profiling
title_full_unstemmed Facets of individual-specific health signatures determined from longitudinal plasma proteome profiling
title_sort facets of individual-specific health signatures determined from longitudinal plasma proteome profiling
publisher Elsevier
series EBioMedicine
issn 2352-3964
publishDate 2020-07-01
description Background: Precision medicine approaches aim to tackle diseases on an individual level through molecular profiling. Despite the growing knowledge about diseases and the reported diversity of molecular phenotypes, the descriptions of human health on an individual level have been far less elaborate. Methods: To provide insights into the longitudinal protein signatures of well-being, we profiled blood plasma collected over one year from 101 clinically healthy individuals using multiplexed antibody assays. After applying an antibody validation scheme, we utilized > 700 protein profiles for in-depth analyses of the individuals’ short-term health trajectories. Findings: We found signatures of circulating proteomes to be highly individual-specific. Considering technical and longitudinal variability, we observed that 49% of the protein profiles were stable over one year. We also identified eight networks of proteins in which 11–242 proteins covaried over time. For each participant, there were unique protein profiles of which some could be explained by associations to genetic variants. Interpretation: This observational and non-interventional study identifyed noticeable diversity among clinically healthy subjects, and facets of individual-specific signatures emerged by monitoring the variability of the circulating proteomes over time. To enable more personal hence precise assessments of health states, longitudinal profiling of circulating proteomes can provide a valuable component for precision medicine approaches. Funding: This work was supported by the Erling Persson Foundation, the Swedish Heart and Lung Foundation, the Knut and Alice Wallenberg Foundation, Science for Life Laboratory, and the Swedish Research Council.
topic Affinity proteomics
Longitudinal profiling
Plasma proteomics
pQTLs
Precision medicine
url http://www.sciencedirect.com/science/article/pii/S2352396420302292
work_keys_str_mv AT teadodigcrnkovic facetsofindividualspecifichealthsignaturesdeterminedfromlongitudinalplasmaproteomeprofiling
AT mungwanhong facetsofindividualspecifichealthsignaturesdeterminedfromlongitudinalplasmaproteomeprofiling
AT ceciliaengelthomas facetsofindividualspecifichealthsignaturesdeterminedfromlongitudinalplasmaproteomeprofiling
AT ragnashaussler facetsofindividualspecifichealthsignaturesdeterminedfromlongitudinalplasmaproteomeprofiling
AT annikabendes facetsofindividualspecifichealthsignaturesdeterminedfromlongitudinalplasmaproteomeprofiling
AT matildadale facetsofindividualspecifichealthsignaturesdeterminedfromlongitudinalplasmaproteomeprofiling
AT fredrikedfors facetsofindividualspecifichealthsignaturesdeterminedfromlongitudinalplasmaproteomeprofiling
AT bjornforsstrom facetsofindividualspecifichealthsignaturesdeterminedfromlongitudinalplasmaproteomeprofiling
AT patrikkemagnusson facetsofindividualspecifichealthsignaturesdeterminedfromlongitudinalplasmaproteomeprofiling
AT inaschuppekoistinen facetsofindividualspecifichealthsignaturesdeterminedfromlongitudinalplasmaproteomeprofiling
AT jacobodeberg facetsofindividualspecifichealthsignaturesdeterminedfromlongitudinalplasmaproteomeprofiling
AT linnfagerberg facetsofindividualspecifichealthsignaturesdeterminedfromlongitudinalplasmaproteomeprofiling
AT andersgummesson facetsofindividualspecifichealthsignaturesdeterminedfromlongitudinalplasmaproteomeprofiling
AT goranbergstrom facetsofindividualspecifichealthsignaturesdeterminedfromlongitudinalplasmaproteomeprofiling
AT mathiasuhlen facetsofindividualspecifichealthsignaturesdeterminedfromlongitudinalplasmaproteomeprofiling
AT jochenmschwenk facetsofindividualspecifichealthsignaturesdeterminedfromlongitudinalplasmaproteomeprofiling
_version_ 1724559850580475904
spelling doaj-3bf396ecd736410fbedbd4648e4a6bf72020-11-25T03:34:14ZengElsevierEBioMedicine2352-39642020-07-0157102854Facets of individual-specific health signatures determined from longitudinal plasma proteome profilingTea Dodig-Crnković0Mun-Gwan Hong1Cecilia Engel Thomas2Ragna S. Häussler3Annika Bendes4Matilda Dale5Fredrik Edfors6Björn Forsström7Patrik K.E. Magnusson8Ina Schuppe-Koistinen9Jacob Odeberg10Linn Fagerberg11Anders Gummesson12Göran Bergström13Mathias Uhlén14Jochen M. Schwenk15Science for Life Laboratory, Department of Protein Science, KTH-Royal Institute of Technology, Tomtebodavägen 23, Stockholm 171 65, SwedenScience for Life Laboratory, Department of Protein Science, KTH-Royal Institute of Technology, Tomtebodavägen 23, Stockholm 171 65, SwedenScience for Life Laboratory, Department of Protein Science, KTH-Royal Institute of Technology, Tomtebodavägen 23, Stockholm 171 65, SwedenScience for Life Laboratory, Department of Protein Science, KTH-Royal Institute of Technology, Tomtebodavägen 23, Stockholm 171 65, SwedenScience for Life Laboratory, Department of Protein Science, KTH-Royal Institute of Technology, Tomtebodavägen 23, Stockholm 171 65, SwedenScience for Life Laboratory, Department of Protein Science, KTH-Royal Institute of Technology, Tomtebodavägen 23, Stockholm 171 65, SwedenScience for Life Laboratory, Department of Protein Science, KTH-Royal Institute of Technology, Tomtebodavägen 23, Stockholm 171 65, Sweden; Department of Genetics, Stanford University School of Medicine, Stanford, CA 94305, USAScience for Life Laboratory, Department of Protein Science, KTH-Royal Institute of Technology, Tomtebodavägen 23, Stockholm 171 65, SwedenDepartment of Medical Epidemiology and Biostatistics, Karolinska Institutet, Nobels väg 12A, Stockholm 171 77, SwedenScience for Life Laboratory, Department of Protein Science, KTH-Royal Institute of Technology, Tomtebodavägen 23, Stockholm 171 65, Sweden; Center for Translational Microbiome Research, Department of Microbiology, Tumor and Cell Biology, Karolinska Institute, Stockholm 171 77, SwedenScience for Life Laboratory, Department of Protein Science, KTH-Royal Institute of Technology, Tomtebodavägen 23, Stockholm 171 65, Sweden; Department of Clinical Medicine, K.G. Jebsen Thrombosis Research and Expertise Center (TREC), UiT the Arctic University of Norway, Tromsø 9010, Norway; Coagulation unit, Department of Hematology, Karolinska University Hospital, Stockholm 171 76, SwedenScience for Life Laboratory, Department of Protein Science, KTH-Royal Institute of Technology, Tomtebodavägen 23, Stockholm 171 65, SwedenDepartment of Molecular and Clinical Medicine, Institute of Medicine, Sahlgrenska Academy, Gothenburg University, Gothenburg 413 45, Sweden; Region Västra Götaland, Department of Clinical Genetics and Genomics, Sahlgrenska University Hospital, Gothenburg 413 45, SwedenDepartment of Molecular and Clinical Medicine, Institute of Medicine, Sahlgrenska Academy, Gothenburg University, Gothenburg 413 45, Sweden; Region Västra Götaland, Department of Clinical Physiology, Sahlgrenska University Hospital, Gothenburg 413 45, SwedenScience for Life Laboratory, Department of Protein Science, KTH-Royal Institute of Technology, Tomtebodavägen 23, Stockholm 171 65, Sweden; Novo Nordisk Foundation Center for Biosustainability, Technical University of Denmark, Lyngby 2800, DenmarkScience for Life Laboratory, Department of Protein Science, KTH-Royal Institute of Technology, Tomtebodavägen 23, Stockholm 171 65, Sweden; Corresponding author.Background: Precision medicine approaches aim to tackle diseases on an individual level through molecular profiling. Despite the growing knowledge about diseases and the reported diversity of molecular phenotypes, the descriptions of human health on an individual level have been far less elaborate. Methods: To provide insights into the longitudinal protein signatures of well-being, we profiled blood plasma collected over one year from 101 clinically healthy individuals using multiplexed antibody assays. After applying an antibody validation scheme, we utilized > 700 protein profiles for in-depth analyses of the individuals’ short-term health trajectories. Findings: We found signatures of circulating proteomes to be highly individual-specific. Considering technical and longitudinal variability, we observed that 49% of the protein profiles were stable over one year. We also identified eight networks of proteins in which 11–242 proteins covaried over time. For each participant, there were unique protein profiles of which some could be explained by associations to genetic variants. Interpretation: This observational and non-interventional study identifyed noticeable diversity among clinically healthy subjects, and facets of individual-specific signatures emerged by monitoring the variability of the circulating proteomes over time. To enable more personal hence precise assessments of health states, longitudinal profiling of circulating proteomes can provide a valuable component for precision medicine approaches. Funding: This work was supported by the Erling Persson Foundation, the Swedish Heart and Lung Foundation, the Knut and Alice Wallenberg Foundation, Science for Life Laboratory, and the Swedish Research Council.http://www.sciencedirect.com/science/article/pii/S2352396420302292Affinity proteomicsLongitudinal profilingPlasma proteomicspQTLsPrecision medicine